Detalhe da pesquisa
1.
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012-2013 to 2018-2019 Seasons, Quebec, Canada.
Clin Infect Dis
; 78(3): 765-774, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819010
2.
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk.
Clin Infect Dis
; 78(2): 461-469, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769158
3.
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
Euro Surveill
; 29(7)2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362622
4.
BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12-17 Years, by Dosing Interval and Duration.
J Infect Dis
; 227(9): 1073-1083, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645782
5.
Standard-dose versus MF59-adjuvanted, high-dose or recombinant-hemagglutinin influenza vaccine immunogenicity in older adults: comparison of A(H3N2) antibody response by prior season's vaccine status.
J Infect Dis
; 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950884
6.
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.
CMAJ
; 195(42): E1427-E1439, 2023 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903524
7.
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
Euro Surveill
; 28(5)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729117
8.
Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
J Infect Dis
; 225(8): 1387-1398, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215564
9.
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
J Infect Dis
; 226(1): 485-496, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084500
10.
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada.
Clin Infect Dis
; 75(1): e805-e813, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460902
11.
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
Clin Infect Dis
; 74(7): 1158-1165, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244723
12.
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
Clin Infect Dis
; 75(11): 1980-1992, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438175
13.
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada.
CMAJ
; 194(47): E1599-E1609, 2022 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507788
14.
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
Euro Surveill
; 27(38)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148674
15.
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017.
Clin Infect Dis
; 71(16): 2285-2288, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442261
16.
Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.
Clin Infect Dis
; 71(7): 1704-1714, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828291
17.
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
Euro Surveill
; 25(7)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32098644
18.
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.
Clin Infect Dis
; 68(10): 1754-1757, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312364
19.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med
; 384(16): 1576-1577, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596348
20.
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic.
Euro Surveill
; 24(15)2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30994107